NCT03686085View on ClinicalTrials.gov

Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

March 10, 2019

Conditions
Intrauterine Device
Interventions
DRUG

Dinoprostone 3 mg

1 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia \& Upjohn, Puurs, Belgium) inserted by the study nurse 6 hours before IUD insertion.

DRUG

placebo vaginal tablet

1 vaginal tablet of placebo inserted by the study nurse 6 hours before IUD insertion.

Trial Locations (1)

11231

Faculty of Medicine Cairo University, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT03686085 - Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women. | Biotech Hunter | Biotech Hunter